Novavax, Inc.
USD9.55
+0.20 (+2.08%)
CEO
John Charles Jacobs
IPO Date
1995-12-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.32
Prev. Close
$9.36
Day Low
$9.30
Day High
$9.77
52W Low
$6.20
52W High
$11.97
Market Cap
$1.57B
Volume
1.59M
| -6.5 |
| 31 Dec 2023 | FY | 38.2% | -98.0% | 76.0% | -30.3% | -0.32 | 0.70 | -0.9 |
| 31 Dec 2022 | FY | 43.5% | -41.1% | 103.8% | -29.1% | -0.87 | 0.69 | -1.2 |
| 31 Dec 2021 | FY | 100.0% | -882.5% | 495.8% | -67.7% | -1.29 | 0.90 | -6.1 |
| 31 Dec 2020 | FY | 100.0% | -1868.2% | -66.7% | -26.4% | 0.75 | 2.15 | -15.3 |
| 31 Dec 2019 | FY | -510.0% | -697.1% | 69.9% | -75.2% | -1.73 | 3.77 | -0.7 |
| 31 Dec 2018 | FY | 100.0% | -538.8% | 110.0% | -88.8% | -1.90 | 2.62 | -3.7 |
| 31 Dec 2017 | FY | 100.0% | -589.5% | 180.6% | -60.8% | -3.12 | 2.76 | -2.0 |
| 31 Dec 2016 | FY | -1449.8% | -1823.5% | 5048.1% | -71.0% | -57.04 | 4.33 | -1.2 |
| 15.5 |
| 30 Sept 2025 | Q3 | 69.5% | -287.3% | 129.2% | -17.2% | -1.60 | 2.27 | -1.7 |
| 30 Jun 2025 | Q2 | 94.1% | 44.5% | 283.1% | 8.0% | 6.07 | 2.36 | 2.4 |
| 31 Mar 2025 | Q1 | 97.9% | 77.8% | -685.6% | 40.1% | -3.02 | 2.06 | 0.5 |
| 31 Dec 2024 | Q4 | 58.5% | -91.8% | 13.0% | -5.2% | -0.37 | 0.98 | -4.0 |
| 30 Sept 2024 | Q3 | 28.3% | -143.5% | 23.0% | -7.1% | -0.44 | 0.93 | -4.2 |
| 30 Jun 2024 | Q2 | 88.9% | 39.1% | -37.6% | 8.9% | -0.54 | 1.04 | 2.9 |
| 31 Mar 2024 | Q1 | 48.0% | -157.2% | 17.0% | -10.9% | -0.26 | 0.90 | -1.1 |
| 31 Dec 2023 | Q4 | 48.9% | -61.2% | 24.9% | -9.9% | -0.32 | 0.70 | -0.8 |